Essentiality of fatty acids, Lipids, vol.39, issue.S1, 1999. ,
DOI : 10.1007/BF02562220
Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms, Am J Clin Nutr Review, vol.52, pp.21-28, 1990. ,
Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988. ,
DOI : 10.1016/0006-2952(88)90782-4
Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.25-382, 2011. ,
DOI : 10.1096/fj.10-161836
URL : https://hal.archives-ouvertes.fr/inserm-00517396
Pro-resolving lipid mediators are leads for resolution physiology, Nature, vol.1821, issue.7503, pp.92-101, 2014. ,
DOI : 10.1038/nature13479
Update on cardiometabolic health effects of ??-3 fatty acids, Current Opinion in Lipidology, vol.25, issue.1, pp.85-90, 2014. ,
DOI : 10.1097/MOL.0000000000000041
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events, JAMA, vol.308, issue.10, pp.1024-1033, 2012. ,
DOI : 10.1001/2012.jama.11374
Detection of lipid radicals by electron paramagnetic resonance spin trapping using intact cells enriched with polyunsaturated fatty acid, J Biol Chem, vol.267, pp.5743-5746, 1992. ,
In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation, Thromb Haemost, vol.56, pp.57-62, 1986. ,
Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro, Biochem J, pp.281-309, 1992. ,
Different metabolic behavior of long-chain n???3 polyunsaturated fatty acids in human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.961, issue.2, pp.262-269, 1988. ,
DOI : 10.1016/0005-2760(88)90121-X
Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity, Lipids, vol.96, issue.3, pp.166-169, 1990. ,
DOI : 10.1007/BF02544332
Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function, J Biol Chem, vol.265, pp.21692-21697, 1990. ,
Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation, AJP: Cell Physiology, vol.304, issue.3, pp.273-279, 2013. ,
DOI : 10.1152/ajpcell.00174.2012
Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, Journal of Thrombosis and Haemostasis, vol.279, issue.3, pp.566-572, 2003. ,
DOI : 10.1046/j.1538-7836.2003.00076.x
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease, Circulation, vol.106, issue.21, pp.2747-2757, 2002. ,
DOI : 10.1161/01.CIR.0000038493.65177.94
The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers, British Journal of Nutrition, vol.314, issue.01, pp.163-173, 1992. ,
DOI : 10.1016/0021-9150(87)90113-4
LDL-platelet interaction under oxidative stress induces macrophage foam cell formation, Thromb Haemost Review, vol.74, pp.560-564, 1995. ,
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients, Diabetes Care, vol.21, issue.9, pp.1511-1516, 1998. ,
DOI : 10.2337/diacare.21.9.1511
Oxidant Stress and Platelet Activation in Hypercholesterolemia, Antioxidants <html_ent glyph="@amp;" ascii="&"/> Redox Signaling, vol.6, issue.4, pp.747-756, 2004. ,
DOI : 10.1089/1523086041361587
Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status, Diabetes, vol.53, issue.4, pp.1046-1051, 2004. ,
DOI : 10.2337/diabetes.53.4.1046
Glutathione Peroxidase Activity and Metabolism of Arachidonic Acid in Peripheral Blood Mononuclear Cells from Elderly Subjects, Clinical Science, vol.85, issue.2, pp.85-203, 1993. ,
DOI : 10.1042/cs0850203
Increasing intakes of the long-chain ??-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men, The FASEB Journal, vol.23, issue.9, pp.2909-2916, 2009. ,
DOI : 10.1096/fj.09-133421
URL : https://hal.archives-ouvertes.fr/inserm-00387440
Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-472, 2010. ,
DOI : 10.1016/j.atherosclerosis.2009.07.049
URL : https://hal.archives-ouvertes.fr/inserm-00416728
Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis, Br J Nutr, vol.101, pp.852-858, 2009. ,
The influence of low intake of n-3 fatty acids on platelets in elderly people, Atherosclerosis, vol.147, issue.1, pp.187-192, 1999. ,
DOI : 10.1016/S0021-9150(99)00171-9
Dose-effect and metabolism of docosahexaenoic acid: Pathophysiological relevance in blood platelets, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.88, issue.1, pp.49-52, 2013. ,
DOI : 10.1016/j.plefa.2012.04.001
URL : https://hal.archives-ouvertes.fr/inserm-00691160
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients, Thromb Haemost, vol.114, pp.289-296, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01140217